Institute of Biomedical Research Corp.
MRES · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $22,374 | $47,428 | $13,754 | $15,391 |
| - Cash | $12 | $0 | $6 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $22,363 | $47,428 | $13,748 | $15,389 |
| Revenue | $19 | $9 | $8 | $13 |
| % Growth | 106.3% | 20.9% | -41.4% | – |
| Gross Profit | $9 | $2 | $3 | $7 |
| % Margin | 47.4% | 22.1% | 35.8% | 56.5% |
| EBITDA | -$302 | $140 | -$165 | -$402 |
| % Margin | -1,569.6% | 1,496.4% | -2,140.5% | -3,054.7% |
| Net Income | -$145 | $159 | -$196 | -$450 |
| % Margin | -753.8% | 1,698.6% | -2,536.7% | -3,417% |
| EPS Diluted | -0 | 0 | -0 | -0 |
| % Growth | -200% | 200% | 50% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |